MAPT and Alzheimer disease: Secondary analysis of the CSF sTREM2 effects on AV1451 tau PET showed that higher CSF sTREM2 was associated with lower tau PET uptake in early Braak‐stage regions, supporting a protective role of TREM2 in the development of key AD pathology.